H.C. Wainwright maintains Buy rating on Viking Therapeutics shares on positive trial data October 10, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:China's rally stumbles, commodities and global shares subdued Back: All Posts Next:Baird maintains Outperform rating on Costco shares on strong sales